… Chronic obstructive pulmonary disease (COPD) represents a significant cause of … chronic
Obstructive Lung Disease (GOLD) guidance refined the classification of patients for treatment …

… developments in bronchodilator therapy for chronic obstructive pulmonary disease (COPD). …
plays an important role in the treatment of chronic obstructive pulmonary disease (COPD). …

… to acute bronchodilator therapy does not predict long-term response to bronchodilator therapy
and … Calverley and colleagues (6) performed acute bronchodilator testing using albuterol, …

… Chronic obstructive pulmonary disease is one of the … therapies are not very effective, and
no current treatment … The mainstay of treatment is bronchodilators for symptom relief, and …

… Spirometric correlates of improvement in exercise performance after anticholinergic
therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:542-9. …

… obstructive airways disease (asthma and chronic obstructive … the course and prognosis
of obstructive airways disease, 6,8,… —namely, that bronchodilator therapy including both an …

… long-acting agents are best used for maintenance therapy. All guidelines suggest that
long-acting bronchodilator therapy should always be considered when patients with COPD are …

… , the FEV 1 change is likely to be less than the change seen in a patient who has successfully
omitted their usual bronchodilator treatment. The importance of this effect has not been …

… bronchodilator on one testing session may benefit symptomatically from long-term bronchodilator
treatment or … [6] Reversibility to albuterol (ie, improvement in FEV 1 of 12% or 200 mL) …

… risk-benefit of inhaled triple therapy, consisting of inhaled … dual bronchodilation for chronic
obstructive pulmonary disease (… single-inhaler dual bronchodilator combination of indacaterol …